Your Cart ( 1 Item )

• A Randomized, Double-Blind, Vehicle-Controlled Crossover Study to Determine the Anti-Pruritic Efficacy, Safety and Local Dermal Tolerability of a Topical Formulation (SRD174 Cream) of the Long-Acting Opiod Antagonist Nalmefene in Subjects With Atopic Dermatitis
  August 2011 | Volume 10 | Issue 8 | Original Article | 853 | Copyright © August 2011
  Jo Lynne Herzog MD,^a James A.Solomon MD PhD,^b Zoe Draelos MD,^c Alan Fleischer Jr. MD,^d Dow Stough MD,^e David I.Wolf MD,^f William Abramovits MD,^g William Werschler MD,^h Emma Green BSc,ⁱ Maeve Duffy PhD,ⁱ Alan Rothaul PhD,ⁱ Robert Tansley MBBSⁱ
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs